ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play?

(Video length 00:13:11)

Are you ready to go to rumble? In this episode of ETF Battles, you'll see a clash between the ARK Genomics Revolution ETF (ARKG) vs. the Global X Genomics & Biotechnology ETF (GNOM). Which ETF is the better play?

Ron DeLegge referees the matchup with guest judges Cinthia Murphy at and Dave Kreinces at ETF Portfolio Management providing their research insights.

Each ETF is judged against the other in key categories like cost, exposure strategy, performance, and a mystery category. Find out who wins the battle!

Disclaimer: Ron DeLegge has analyzed and graded more than $125 million with his Portfolio Report Card grading system. Does ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.